Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06142955 · ClinicalTrials.gov registry record · NA

Transcranial Magnetic Stimulation (TMS) to Treat Depression in Autism Spectrum Disorder

A NA study of Autism Spectrum Disorder, sponsored by Yale University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06142955 is a NA study of Autism Spectrum Disorder that is actively recruiting participants, run by Yale University. The registered enrollment target is 60 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06142955, a NA study of Autism Spectrum Disorder, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This study will assess clinical and behavioral measures along with electroencephalogram (EEG), event-related potentials (ERPS), and eye-tracking (ET) prior to and following a single intermittent Theta Burst Stimulation (iTBS) session to provide preliminary insight into the potential of TMS as an intervention for depression in individuals with Autism Spectrum Disorder (ASD).

Conditions Studied

Autism Spectrum Disorder

Interventions

  • DEVICE MAGSTIM Rapid2 TMS system

Study Locations (1)

Connecticut

  • Yale Psychiatric Hospital - New Haven

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-04-30
Est. Completion 2026-12
Phase NA

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06142955

The ClinicalTrials.gov registry entry for NCT06142955 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (56% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which MAGSTIM Rapid2 TMS system is the first listed.

NCT06142955 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT06142955 about?

NCT06142955 is a clinical study titled "Transcranial Magnetic Stimulation (TMS) to Treat Depression in Autism Spectrum Disorder". This study will assess clinical and behavioral measures along with electroencephalogram (EEG), event-related potentials (ERPS), and eye-tracking (ET) prior to and following a single intermittent Theta Burst Stimulation (iTBS) session to provide preliminary insight into the potential of TMS as an int...

What is the current status of trial NCT06142955?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-04-30. Estimated completion is 2026-12.

What conditions does trial NCT06142955 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder.

What interventions are being tested in trial NCT06142955?

The interventions under investigation include: MAGSTIM Rapid2 TMS system (DEVICE).

Who is sponsoring clinical trial NCT06142955?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06142955 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Autism Spectrum Disorder

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.